Download presentation
Presentation is loading. Please wait.
Published byAugustus Chambers Modified over 9 years ago
1
Adult Immunization 2010 MMR Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010
2
Measles-Mumps-Rubella Vaccine (MMR) Contains live attenuated viruses 1-dose efficacy varies from 80% (mumps) to 95% (measles and rubella) Duration of immunity probably lifelong Schedule is 2 doses All adults born in 1957 or later should have documentation of at least 1 dose (or other evidence of immunity)
3
Adults at High Risk for Measles College students International travelers Healthcare personnel
4
MMR Vaccine Contraindications Severe allergic reaction to vaccine component or following prior dose Pregnancy Immunosuppression
5
Measles Vaccine and HIV Infection MMR recommended for persons with asymptomatic and minimally symptomatic HIV infection NOT recommended for persons with evidence of severe immuno- suppression Prevaccination HIV testing of an otherwise healthy person not recommended
6
MMR Vaccination of Women of Childbearing Age Ask if pregnant or likely to become so in next 4 weeks Exclude those who say "yes“ For others – explain theoretical risks – vaccinate
7
MMR Vaccine Precautions Moderate or severe acute illness Recent receipt of a blood product History of thrombocytopenia or thrombycytopenic purpura
8
MMR Adverse Reactions Fever5%-15% Rash 5% Joint symptoms 25% Thrombocytopenia<1/30,000 doses Parotitis rare Deafness rare Encephalopathy <1/1,000,000 doses
9
National Center for Immunization and Respiratory Diseases Contact Information Telephone (800) CDC-INFO Email nipinfo@cdc.govnipinfo@cdc.gov Website http://www.cdc.gov/vaccines/ http://www.cdc.gov/vaccines/ Broadcast Updates and Resources Web Page http://www.cdc.gov/vaccines/ed/webcasts.htm
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.